Baylor Scott & White Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Baylor Scott & White Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9428
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical research. It offers medical services in the areas of emergency care, cancer care, behavioral and psychological health, heart health, breast care, body composition analysis, cholesterol, blood pressure, pediatric care and primary care, among others. The organization conducts its research through various institutes and centers. It operates through its hospitals and patient care sites across the US. Baylor Scott & White is headquartered in Dallas, Texas, the US.

Baylor Scott & White Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
Baylor Scott & White Health Forms Joint Venture with AccentCare 12
Abzena and Baylor Scott & White Research Institute Form Joint Venture 13
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14
TGen Enters into Research Agreement with Baylor Research Institute 15
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17
Licensing Agreements 19
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19
Baylor Scott & White Health – Key Competitors 21
Baylor Scott & White Health – Key Employees 22
Baylor Scott & White Health – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Apr 10, 2017: Baylor Scott & White Health Opening Austin-Area Westlake Clinic 25
Mar 30, 2017: Baylor Scott & White Health Convenient Care Clinics to Open across Dallas-Fort Worth Area in Tom Thumb Stores 26
Mar 29, 2017: Baylor Scott & White Health Opening Kyle, Texas, Clinic 27
Feb 22, 2017: Baylor Scott & White Health Opens Cancer Center in College Station 28
Feb 08, 2017: Baylor Scott & White Health Increasing Health and Wellness Options with New Medical Center in Pflugerville 29
Jan 17, 2017: Baylor Scott & White Health Opening Austin-Area Primary Care Clinics, Offering App-Based Care Delivery Downtown 30
Jan 04, 2017: New Retail Pharmacy Opens Inside the Baylor Scott & White Medical Center – College Station 31
Corporate Communications 32
Mar 12, 2018: Baylor Scott And White Medical Center Frisco Announces New CEO 32
Nov 07, 2017: Baylor Scott & White Health Strengthens Executive Leadership Team with New Hire and Promotions 33
Legal and Regulatory 34
Jan 13, 2017: Baylor Scott & White Charles A. Sammons Cancer Center – McKinney Accredited by the Commission on Cancer of the American College of Surgeons 34
Government and Public Interest 35
Mar 29, 2017: Study Identifies Gene Mutation that Boosts Aspirin’s Cancer Prevention Benefits 35
Mar 06, 2017: New Colon Cancer Biomarkers May Guide Development of Personalized Treatment 36
Feb 13, 2017: Dallas Researchers Identify How Common Gut Bacteria May Cause Colon Cancer 37
Product News 38
Mar 03, 2017: Baylor Scott White Health Introduces Robotic-Assisted Cardiac Catheterization Technology to DFW 38
Other Significant Developments 39
Mar 22, 2018: Blue Cross and Blue Shield of Texas, Baylor Scott & White Health Announce New Agreement That Will Expand Access to Care 39
Jul 13, 2017: Baylor Scott & White Health Selects Kyruus’ Solutions to Enhance Provider Data Management and Patient Access 40
Mar 28, 2017: The Heart Hospital Baylor Plano Performs First Robotic-Assisted Peripheral Intervention in Texas 41
Mar 13, 2017: Baylor Scott & White Cancer Center – College Station Brings Care Where it’s Needed Most 42
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Key Facts 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Deals By Therapy Area, 2012 to YTD 2018 9
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
Baylor Scott & White Health Forms Joint Venture with AccentCare 12
Abzena and Baylor Scott & White Research Institute Form Joint Venture 13
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14
TGen Enters into Research Agreement with Baylor Research Institute 15
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19
Baylor Scott & White Health, Key Competitors 21
Baylor Scott & White Health, Key Employees 22
Baylor Scott & White Health, Subsidiaries 24

List of Figures
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Baylor Scott & White Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Serco Group plc:企業の戦略・SWOT・財務情報
    Serco Group plc - Strategy, SWOT and Corporate Finance Report Summary Serco Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Futuren (FTRN)-エネルギー分野:企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Precision Optics Corporation Inc (PEYE):企業の財務・戦略的SWOT分析
    Summary Precision Optics Corporation Inc (Precision Optics) is a medical device company that designs, develops, manufactures and distributes optics and optical systems for medical, biomedical, and industrial applications. The company provides custom optics solutions such as design and prototyping, f …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Chubu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Infratil Ltd (IFT):企業の財務・戦略的SWOT分析
    Infratil Ltd (IFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Formosa Petrochemical Corp (6505):企業の財務・戦略的SWOT分析
    Formosa Petrochemical Corp (6505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cancer Research Technology Ltd-医療機器分野:企業M&A・提携分析
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • ALPCO Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary ALPCO Diagnostics (ALPCO) is a life science company that imports and distributes immunoassay based products. The company offers immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It provides food additives, …
  • Mitchells & Butlers plc:企業のM&A・事業提携・投資動向
    Mitchells & Butlers plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitchells & Butlers plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Rodin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodin Therapeutics Inc (Rodin Therapeutics) discovers and develops novel medicines targeting epigenetics and novel chemical strategies for cognitive impairment of neurological and neuropsychiatric disorders. Its translational therapeutic strategy harnesses the power of epigenetic regulation …
  • Medusa Mining Ltd:企業の戦略・SWOT・財務分析
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Silicon Laboratories Inc (SLAB):企業の財務・戦略的SWOT分析
    Silicon Laboratories Inc (SLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sonic Healthcare Ltd (SHL)-医療機器分野:企業M&A・提携分析
    Summary Sonic Healthcare Ltd (Sonic Healthcare) Sonic Healthcare is a medical diagnostics company that provides laboratory and diagnostic imaging services. The company provides laboratory medicine, pathology, radiology, diagnostic imaging and primary care medical services. It operates Australia's la …
  • Algonquin Power & Utilities Corp (AQN):電力:M&Aディール及び事業提携情報
    Summary Algonquin Power & Utilities Corp. (APUC) generates, transmits and distributes energy. It generates electricity through non-regulated renewable and clean energy and thermal generation facilities across North America. The company distributes electricity in California and New Hampshire; natural …
  • SJVN Ltd (SJVN):企業の財務・戦略的SWOT分析
    SJVN Ltd (SJVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析
    Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆